d-Cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry

Magali Millecamps, Maria V. Centeno, Hector H. Berra, Charles N. Rudick, Simona Lavarello, Tatiana Tkatch, A. Vania Apkarian*

*Corresponding author for this work

Research output: Contribution to journalArticle

80 Scopus citations

Abstract

Human brain imaging studies suggest that chronic neuropathic pain has a strong emotional component that is mediated by medial prefrontal cortex (mPFC) activity; in rodents, the mPFC is involved in emotional and cognitive aspects of behavior, including the extinction of Pavlovian fear conditioning. Together, these findings suggest that the cortex may modulate the memory trace of pain. As d-cycloserine (DCS), a partial agonist of the NMDA receptor, can enhance learning and potentiate the extinction of acquired fear, in the present study we tested its efficacy in neuropathic pain behavior. In rats with spared nerve injury (SNI), repeated daily oral administration of DCS reduced mechanical sensitivity of the injured limb in a dose-dependent manner; this effect continued for weeks after the cessation of DCS treatment. In addition, re-exposure to DCS further enhanced antinociceptive behavior. Repeated oral DCS administration also reduced cancer chemotherapy drug-induced neuropathic pain behavior. Infusions of DCS directly into the mPFC (especially within prelimbic cortex) or the amygdala (but not into thalamus, insula, or occipital cortex) acutely induced antinociception in SNI rats. The antinociceptive effect of intra-mPFC DCS infusions was mimicked by NMDA and glycine, and blocked by HA 966. In the mPFC of SNI rats, NR2B expression was down-regulated; however, this effect was reversed with repeated oral DCS. Lastly, infusions of DCS into mPFC reversed place avoidance behavior induced by mechanical stimulation of the injured paw in SNI rats. These findings indicate that limbic NMDA-mediated circuitry is involved in long-term reduction in neuropathic pain behavior.

Original languageEnglish (US)
Pages (from-to)108-123
Number of pages16
JournalPain
Volume132
Issue number1-2
DOIs
StatePublished - Nov 2007

Keywords

  • Allodynia
  • Amygdala
  • Aversion
  • Fear extinction
  • NMDA receptor
  • NR2B
  • Prefrontal cortex

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'd-Cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry'. Together they form a unique fingerprint.

  • Cite this